InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
3
T+90 hit rate
31%
T+90 mean return
-3.0%
Across 16 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by LEONARD JOHN M, Chief Executive Officer. Director active across 2 companies, notably Intellia Therapeutics, Inc.. In total, 21 reports have been published. Split: 0 buy · 3 sells. Total volume traded: €1.1m. Activity tracked since 19 August 2021. The latest transaction was filed on 23 April 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations21 total
1,571 shares0Common StockSEC:0001628280-26-027609:0
1,592 shares0Common StockSEC:0001478242-25-000072:0
136,000 shares0Common StockSEC:0000950170-25-032248:0
26,807 shares@ US$12.1812.8% of flowCommon StockSEC:0000950170-25-003012:0
7,850 sharesCommon StockSEC:0000950170-25-001236:0
1,047 shares0Common StockSEC:0001478242-24-000079:0
113,586 shares0Common StockSEC:0000950170-24-025900:0
19,223 shares@ US$29.4620.9% of flowCommon StockSEC:0000950170-24-002516:0
7,848 sharesCommon StockSEC:0000950170-24-001197:0
1,063 shares0Common StockSEC:0001478242-23-000075:0
91,036 shares0Common StockSEC:0001209191-23-015764:0
6,673 shares@ US$37.219.5% of flowCommon StockSEC:0001209191-23-002425:0
7,848 sharesCommon StockSEC:0001209191-23-001495:0
995 shares0Common StockSEC:0001478242-22-000072:0
7,848 sharesCommon StockSEC:0001209191-22-016537:0
11,637 shares@ US$13.405.3% of flowCommon StockSEC:0001209191-21-054331
11,637 shares@ US$13.400.0069% mcap9.4% of flowCommon StockSEC:0001209191-21-054331:0
27,139 shares@ US$13.400.016% mcap22.1% of flowCommon StockSEC:0001209191-21-053305:0
27,139 shares@ US$13.4012.5% of flowCommon StockSEC:0001209191-21-053305
22,682 shares@ US$13.400.014% mcap18.5% of flowCommon StockSEC:0001209191-21-052835:0
22,682 shares@ US$13.4010.5% of flowCommon StockSEC:0001209191-21-052835
21 of 21 declarations
About LEONARD JOHN M
John M. Leonard serves as President and Chief Executive Officer of Intellia Therapeutics, Inc. and IQVIA Holdings Inc. He leads the operations of both companies, focusing on innovation in biotechnology and health services. Intellia Therapeutics specializes in gene therapy, while IQVIA focuses on health data and analytics.
